Kevin Koch - Feb 5, 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
President and CEO, Director
Signature
/s/John R. Moore Attorney-in-Fact for Kevin Koch
Stock symbol
EWTX
Transactions as of
Feb 5, 2025
Transactions value $
-$273,962
Form type
4
Date filed
2/7/2025, 04:38 PM
Previous filing
Aug 14, 2024
Next filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $1.55K +8.64K +59.65% $0.18 23.1K Feb 5, 2025 Direct
transaction EWTX Common Stock Sale -$259K -8.64K -37.36% $30.03 14.5K Feb 5, 2025 Direct F1, F2
transaction EWTX Common Stock Options Exercise $11.8K +900 +6.22% $13.11 15.4K Feb 6, 2025 Direct
transaction EWTX Common Stock Sale -$28K -900 -5.85% $31.13 14.5K Feb 6, 2025 Direct F1, F3
holding EWTX Common Stock 260K Feb 5, 2025 KTK Family Enterprise, LLC F4
holding EWTX Common Stock 26.4K Feb 5, 2025 Nicole M. Soldow Heritage Trust F5
holding EWTX Common Stock 26.4K Feb 5, 2025 Adrienne R. Koch Heritage Trust F6
holding EWTX Common Stock 26.4K Feb 5, 2025 Matthew K. Koch Heritage Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -8.64K -16.87% $0.00 42.5K Feb 5, 2025 Common Stock 8.64K $0.18 Direct
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -900 -2.12% $0.00 41.6K Feb 6, 2025 Common Stock 900 $0.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024.
F2 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $30.1311, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 These shares are held directly by the KTK Family Enterprise, LLC for the which the Reporting Person serves as Manager.
F5 These shares are held directly by the Nicole M. Soldow Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
F6 These shares are held directly by the Adrienne R. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
F7 These shares are held directly by the Matthew K. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.